Affinia Therapeutics

📍 Waltham, United States🗓 Founded 2019👥 63 employees💰 Last funded Dec 2019
Biotechnology Research🌐 affiniatx.com
Website LinkedIn
Affinia Therapeutics is an innovative gene therapy company focused on broadening the reach of gene therapy. Our proprietary Affinia Rationally-designed Therapies (ART) platform is created to address key limitations of conventional gene therapies, by developing novel capsids, novel promoters, and novel manufacturing approaches to developing gene therapies for rare and prevalent devastating diseases. We are backed by a strong syndicate of life science investors and have ambitious plans to have a dramatic impact on the lives of patients around the world. As an early employee you will play a key role in setting our culture and values. You will be working alongside the founding management team who have a track record of success in the industry. The pace of work is dynamic, fast and fun. Our brand new Site Includes: State of the Art lab space & Equipment- Healthy Cafe, Outdoor Patio, State of the Art Gym/Yoga Studio, Lounge ( Pool Table/ Golf Simulator ), Free/Plentiful Parking and More! Join Us!
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Affinia Therapeutics?
Affinia Therapeutics has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Affinia Therapeutics last raise funding?
The most recent investment in Affinia Therapeutics recorded on gritt.io was in December 2019.
When was Affinia Therapeutics founded?
Affinia Therapeutics was founded in 2019.
What industry is Affinia Therapeutics in?
Affinia Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Affinia Therapeutics based?
Affinia Therapeutics is headquartered in Waltham, United States.